High-dose chemotherapy and multiple sclerosis. - Wikidata - wikimedia - TriplyDB

High-dose chemotherapy and multiple sclerosis.

High-dose chemotherapy and multiple sclerosis.

http://www.wikidata.org/entity/Q37822255

about

High-dose chemotherapy and multiple sclerosis.

http://www.wikidata.org/entity/Q37822255

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

High-dose chemotherapy and multiple sclerosis.

@en

High-dose chemotherapy and multiple sclerosis.

@nl

type

label

High-dose chemotherapy and multiple sclerosis.

@en

High-dose chemotherapy and multiple sclerosis.

@nl

prefLabel

High-dose chemotherapy and multiple sclerosis.

@en

High-dose chemotherapy and multiple sclerosis.

@nl

P1433

Q37822255-DE8D917C-1913-4F4F-98F1-CE48011AC3EA

P1476

Q37822255-0D3AE298-2A0F-4FBB-9231-AC93420DFF3C

P2093

Q37822255-47B8AAA0-E44F-4C92-8B24-9A468BFC1A65

Q37822255-FDA79484-C1FC-45B1-B54F-8CD1D1DF8965

P2860

Q37822255-03CEDDC1-EFC3-4F61-A880-5F77F23DB08C

Q37822255-0706064C-D926-41CF-851B-94F586C00221

Q37822255-09D7696C-E722-40DF-A7FC-40931E4723B3

Q37822255-107F53C2-A51F-436C-81C6-1A7616DC2C5B

Q37822255-170EEAE9-DC04-431B-8203-DED66E8EDAFE

Q37822255-17C4803D-734C-4BD4-9806-9BEB5D562625

Q37822255-1A13DA75-0A35-4F73-AAAD-CB1F3AAF51FE

Q37822255-265C1D21-2F0F-4AD6-B789-7409C212E6F1

Q37822255-2A73CAD9-E31F-4575-AC8D-79E586072D48

Q37822255-2BC7F7E9-46D0-4253-A9AF-4F86274DB5E1

P304

Q37822255-AA952612-2168-4B1A-BCB3-7D812D5C0CA7

P31

Q37822255-04DBF74F-EF32-44FB-BBF8-05D7E707FD25

Q37822255-feb69f8a-0d58-4016-9546-7404bf88b645

P356

Q37822255-56E15EF2-4D67-4E2C-9652-D681D37C10FA

P433

Q37822255-596A5901-3548-453B-BFB6-EC1CFAE02C0B

P478

Q37822255-0FA56F36-D4F4-41E0-8BB9-5CD228BD7909

P577

Q37822255-FAD185E6-A44A-4FBC-BEA7-C729BC9D2FA5

P698

Q37822255-13E75FF8-E271-4EFF-AC1F-4CB50C9DA7CB

P921

Q37822255-51305E19-E57A-421E-BD6B-377AC49B4FC6

Q37822255-A53125BF-25CD-4E27-AFA5-3AF7EF7255C2

P932

Q37822255-1AEDA1E9-7C4A-4B3B-93D0-EDB8B5F7AD99

P356

CCO.0B013E328342C6B3

P1433

Current Opinion in Oncology

P1476

High-dose chemotherapy and multiple sclerosis.

@en

P2093

Daniel Harrison

http://www.w3.org/2001/XMLSchema#string

Douglas E Gladstone

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up

High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial

P304

221-226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CCO.0B013E328342C6B3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21169833

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

4696039

http://www.w3.org/2001/XMLSchema#string